Cancer is one of the leading causes of morbidity and mortality worldwide, with approximately 14 million new cases annually and rising. The World Health Organization estimates the number of new cases is expected to rise by about 70 per cent over the next two decades. It is also the second leading cause of death globally, with one in six deaths worldwide due to cancer.

Radiation therapy is a highly effective and safe treatment for cancer with approximately 40 per cent of all cures attributable to radiation therapy. Around one in every two cancer patients will benefit from radiation therapy at some stage.

Our overarching aims are to:

1. Identify mechanisms of radiation resistance using a combination of imaging and tumour specimen biomarkers
Combining radiomics, genomics and proteomics to provide maximal clinical information

2. Overcome radiation resistance using novel radiation/drug combinations and advanced radiation delivery technologies